🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhigang Zhang

Hubei University Of Economics

ORCID: 0000-0001-5422-3013

Also affiliated with Hubei University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study”.

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet(2023)10.1016/s0140-6736(23)01857-3

N/A

4.7DataRank · unranked

264 citations

Jonathan T. Yang, Juber Patel, Annemarie F. Shepherd, Juliana Eng, Randy Yeh +44 more

scIGANs: single-cell RNA-seq imputation using generative adversarial networks

Nucleic Acids Research(2020)10.1093/nar/gkaa506

N/A

0DataRank · unranked

199 citations

Zhigang Zhang, Lei You, Jiajia Liu, Zhiwei Fan, Xiaobo Zhou +1 more

Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case–control study

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101352

N/A

0DataRank · unranked

2 citations

Teeradon Treechairusame, Amir H. Safavi, Yingzhi Wu, Zhigang Zhang, A. Shamseddine +11 more